We have recently reported that the upregulation of WNT7A (uniquely among 19 WNT ligands) results in accelerated development and progression of ovarian cancer (OvCa), and plays a critical role in tumor progression mediated by the WNT7A/CTNNB1 signaling pathway [16, 17]. Here, WNT7A is linked to ovarian carcinoma.